Overview

The Bioequivalence Of Two Different Lurasidone Formulations In Patients

Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
A Phase I, Bioequivalent Study between 2 Formulations of Lurasidone HCl
Phase:
Phase 1
Details
Lead Sponsor:
Sunovion
Treatments:
Lurasidone Hydrochloride